ClinGen develops new method for evaluating genomic variation and its role in disease prevention

A major question associated with using genomic medicine in practice is: How should doctors treat patients with disease-associated differences in their genetic code? NHGRI's Clinical Genome Resource (ClinGen), co-funded by NCI, has developed a score-based method to evaluate genomic variants that call for increased clinical focus. The guide will help clinicians decide what medical practices best prevent disease in at-risk patients. The study appears April 28th in Genetics in Medicine.

Source: NHGRI Homepage Highlights - April 28, 2016 Category: Genetics & Stem Cells Source Type: news